
Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported
Franzini, Marianno, Valdenassi, Luigi, Ricevuti, Giovanni, Chirumbolo, Salvatore, Depfenhart, Markus, Bertossi, Dario, Tirelli, UmbertoVolume:
88
Journal:
International Immunopharmacology
DOI:
10.1016/j.intimp.2020.106879
Date:
November, 2020
Fichier:
PDF, 442 KB
2020